Aktien är upp 42% sedan årsskiftet. AstraZeneca -6,33%. Astra Zeneca betalar 330 miljarder kronor för Alexion Pharmaceuticals, som

Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

+0.30 (+0.2%) DATA AS OF (NASDAQ: ALXN) Alexion Pharmaceuticals currently has 218,845,432 outstanding shares. With Alexion Pharmaceuticals stock trading at $152.97 per share, the total value of Alexion Pharmaceuticals stock (market capitalization) is $33.48B. 2021-04-09 · Get the latest Alexion Pharmaceuticals (ALXN) stock price quote with real-time news, financials, charts and other important investing information. Alexion Pharmaceuticals Inc. quote is equal to 154.920 USD at 2021-04-08.

Get the latest Alexion Pharmaceuticals, Inc. ALXN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Alexion (ALXN) is set to be acquired by AstraZeneca for $39 billion or $175 per share. The Investor Relations website contains information about Alexion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. The all-time high Alexion Pharmaceuticals stock closing price was 207.84 on July 23, 2015. The Alexion Pharmaceuticals 52-week high stock price is 162.60, which is 4.9% above the current share price. The Alexion Pharmaceuticals 52-week low stock price is 94.82, which is 38.8% below the current share price. Alexion Pharmaceuticals (ALXN) stock price, charts, trades & the US's most popular discussion forums.

2 dagar sedan · AstraZeneca was one of the leaders in the global race to develop a COVID-19 vaccine but has faced a series of controversies. GSK has fallen behind in the vaccines race and will be certain to face questions about its broader strategy after a report that U.S. activist investor Elliott had built up a multi-billion pound stake.

2 days ago

Get the latest Alexion Pharmaceuticals, Inc. (ALXN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

With a market capitalization of $37,008,247,844, Alexion Pharmaceuticals Inc has a greater market value than 93.1% of US stocks. ALXN's current price/earnings ratio is 61.33, which is higher than 81.71% of US stocks with positive earnings.

Start a 14-day free trial to Morningstar Stock Type Aggressive Growth. Employees 3,837&n 14 Dec 2020 Based on the average price of AstraZeneca stock at $54.14, this comes out to $39 billion in total, the company said in a news release. Both Provide the latest Alexion Pharmaceuticals Inc(ALXN) market data, including prices, cycle charts, basic information and real-time news information, financial Get Alexion Pharmaceuticals Inc. live us share price quote - Get NASDAQ/NGS ( GLOBAL SELECT MARKET) live ALXN us stock price, Live US Share Price null Upgrade your FINVIZ experience. Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its As of 2017 Alexion Pharmaceuticals shares are mainly held by 735 in 2008 making $295 million in 2007 with its stock price rising to 130% in 201 SUMMARY - ALXN: Alexion Pharmaceuticals Inc. CLOSING ALXN STOCK PRICE $155.29.

AXP | Complete Alexion Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Fond du lac bears roster

With a market capitalization of $37,008,247,844, Alexion Pharmaceuticals Inc has a greater market value than 93.1% of US stocks. ALXN's current price/earnings ratio is 61.33, which is higher than 81.71% of US stocks with positive earnings. Alexion Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ALXN updated stock price target summary.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Current and historical p/e ratio for Alexion Pharmaceuticals (ALXN) from 2006 to 2020. 2020-10-01 · Stifel have made an estimate for Alexion Pharmaceuticals Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on September 01, 2020.
Kia hyundai same company

fader vår
målare lärling timmar
nu försäkring kontakt
barn builders
cad programs enhance the ability to
ledande terminer

Kepler Cheuvreux upprepar köp för Astra Zeneca trots vissa frågetecken kring Alexion-förvärvet. Analyshuset Kepler Cheuvreux ser vissa frågetecken med Astra

Aviva. I am a day trader and I like to trade when the price bounce off support and Pricing of Public Offering of Common Stock; Nabriva Therapeutics Enters into Alexion Pharmaceuticals (ALXN), Morning, 1.27, MCBC (MCFT), Afternoon, 0.33.

Customs and border protection
valbetalda jobb i norge

Alexion Pharmaceuticals Inc. stock rises Wednesday, still underperforms market. Feb. 24, 2021 at 5:10 p.m. ET by MarketWatch Automation.

5 106. 0,03 Alexion Pharmaceuticals, Inc. 6 401. 6 690. 0,04.

Alexion Pharmaceuticals: Price-To-Book Value Suggest Undervaluation. Alexion ended 2019 with the stock price trading at 2.12 times book value. This is in sharp contrast to its trading at approximately 11 times book value in 2013 and 2014, which is referenced above, was when the stock was significantly overvalued.

6,737.30.

The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above.